Skip to main content
Caplight Logo









BioID

BioID

Private
GermanyCybersecurityhttps://bioid.com

Last Round

Spinoff

Jan 1, 1998

Company Overview

BioID operates in Cybersecurity and is based in Germany. It was founded in 1998.

BioID is a cybersecurity and SaaS company that provides cloud-based biometric authentication software, including facial recognition and liveness detection.

Sector

Cybersecurity

Verticals

Digital Identity, Identity & Access, Computer Vision, Compliance & Risk, API Management

Business Model

B2B2C

Customer Profile

Usage-Based SaaS, Freemium, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

BioID Comparables

Compare BioID with similar companies based on industry and business-model similarity.

BioID comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FaceTec
83%
iProov
78%
Paravision
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

BioID Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SpinoffJan 1, 1998
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ho Chang

CEO & Chairman, CEO & Managing Director

Executive Team

Robert Frischholz

CTO

Executive Team

For institutional investors. Book with your work email.

BioID Investors

Notable investors and investment history

BioID investors
InvestorRounds
Fraunhofer VentureSpinoff
Triangle Venture Capital GroupVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 24, 2026

    Grew 88% QoQ, from 8 to 15 employees.

  • Jan 21, 2026

    Monthly visitors increased 45% MoM, reaching 61K.

Book a demo to see all signals

For institutional investors. Book with your work email.

BioID Filings

Explore SEC and related filing metadata, where available.

BioID filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about BioID's valuation, stock price, and market status.

Is BioID a public or private company?

BioID is a private company.

What is the current stock price of BioID?

BioID is a private company, so its shares have no public market price. Caplight tracks BioID's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is BioID worth (valuation)?

Valuation information for BioID is not publicly available.

Can I buy BioID stock?

BioID shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was BioID's last funding round?

BioID's most recent funding round was Spinoff on January 1, 1998.

Who are the main investors in BioID?

Key investors in BioID include Fraunhofer Venture, Triangle Venture Capital Group.

Will BioID IPO soon?

No public IPO plans have been announced for BioID.

How can I track BioID secondary market activity?

Caplight tracks bids, offers, and trades in BioID's shares on secondary markets.

Firmographic Details

HeadquartersGermany
Employee Range15
Year Founded1998
Last FundingJan 1, 1998

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?